Fig. 1From: Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case reportPositive finding by PET-CT scan at baseline. a Primary lung tumor, b–d metastatic lymph nodes, and (e) brain metastasisBack to article page